BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3013909)

  • 1. Ligand-receptor interactions: detailed evaluation of occupancy-dependent affinity.
    Faguet GB
    J Cell Biochem; 1986; 31(1):75-86. PubMed ID: 3013909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of phytohemagglutinin to porcine lymphocyte receptors. Time-course studies and comparative binding isotherms using whole cells or cellular receptors incorporated into phospholipid vesicles.
    Dupuis G; Bastin B
    Can J Biochem Cell Biol; 1985 Sep; 63(9):1033-43. PubMed ID: 4075227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
    Yang JS; Olsen RW
    Mol Pharmacol; 1987 Aug; 32(1):266-77. PubMed ID: 3039341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of receptor sites from Scatchard and Klotz graphs: complementary approaches.
    Faguet GB
    J Cell Biochem; 1986; 31(3):243-50. PubMed ID: 2856397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic domains mediate the ligand-induced affinity shift of guanylyl cyclase C.
    Deshmane SP; Parkinson SJ; Crupper SS; Robertson DC; Schulz S; Waldman SA
    Biochemistry; 1997 Oct; 36(42):12921-9. PubMed ID: 9335551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of cyclosporine by human lymphocytes and phospholipid vesicles.
    LeGrue SJ; Friedman AW; Kahan BD
    J Immunol; 1983 Aug; 131(2):712-8. PubMed ID: 6863928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the rabbit ventricular myocardial receptor for angiotensin II. Evidence for two sites of different affinities and specificities.
    Wright GB; Alexander RW; Ekstein LS; Gimbrone MA
    Mol Pharmacol; 1983 Sep; 24(2):213-21. PubMed ID: 6310363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cluster-arranged cooperative model: a model that accounts for the kinetics of binding to A1 adenosine receptors.
    Franco R; Casadó V; Ciruela F; Mallol J; Lluis C; Canela EI
    Biochemistry; 1996 Mar; 35(9):3007-15. PubMed ID: 8608139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of cooperative ligand binding: applications to the insulin receptor.
    De Lean A; Rodbard D
    Fed Proc; 1980 Jan; 39(1):116-20. PubMed ID: 7351239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
    Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
    Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of interleukin 2 high-affinity binding by lymphocyte-derived tetrahydrobiopterin: pterins as potential participants in the control of interleukin 2 receptor assembly.
    Ziegler I; Schwuléra U
    J Cell Biochem; 1989 Oct; 41(2):103-12. PubMed ID: 2613745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
    Morris ED; Alpert NM; Fischman AJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of receptor-ligand interactions in immune responses.
    Long M; Lü S; Sun G
    Cell Mol Immunol; 2006 Apr; 3(2):79-86. PubMed ID: 16696894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
    Dunn SM; Raftery MA
    Biochemistry; 1997 Apr; 36(13):3846-53. PubMed ID: 9092814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding interaction studies of selected receptor subpopulations after partial cross-linking receptor-ligand complexes with a photoactivated heterobifunctional reagent.
    Faguet GB; Beebe D
    J Clin Invest; 1986 Jul; 78(1):67-72. PubMed ID: 3522629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of human syncytiotrophoblast plasma membrane-soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor.
    Khalfoun B; Degenne D; Crouzat-Reynes G; Bardos P
    J Immunol; 1986 Aug; 137(4):1187-93. PubMed ID: 3016089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.